New drug helps dialysis patients manage dangerous phosphorus levels
NCT ID NCT06745531
First seen Nov 17, 2025 · Last updated May 21, 2026 · Updated 28 times
Summary
This study tested a new drug called TS-172 in 101 adults on hemodialysis who had high phosphorus levels. The goal was to see if the drug could help bring phosphorus down to a safer range. Participants took TS-172 or a placebo for several weeks, and researchers measured changes in blood phosphorus and related minerals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Taisho Pharmaceutical Co., Ltd selected site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.